425 related articles for article (PubMed ID: 31279905)
41. Th1-Biased Hepatitis C Virus-Specific Follicular T Helper-Like Cells Effectively Support B Cells After Antiviral Therapy.
Zoldan K; Ehrlich S; Killmer S; Wild K; Smits M; Russ M; Globig AM; Hofmann M; Thimme R; Boettler T
Front Immunol; 2021; 12():742061. PubMed ID: 34659236
[TBL] [Abstract][Full Text] [Related]
42. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors.
Leadbetter EA; Rifkin IR; Hohlbaum AM; Beaudette BC; Shlomchik MJ; Marshak-Rothstein A
Nature; 2002 Apr; 416(6881):603-7. PubMed ID: 11948342
[TBL] [Abstract][Full Text] [Related]
43. Hepatitis C virus infection and cryoglobulinaemia.
Lunel F; Musset L
Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
[TBL] [Abstract][Full Text] [Related]
44. Biased IGH VDJ gene repertoire and clonal expansions in B cells of chronically hepatitis C virus-infected individuals.
Tucci FA; Kitanovski S; Johansson P; Klein-Hitpass L; Kahraman A; Dürig J; Hoffmann D; Küppers R
Blood; 2018 Feb; 131(5):546-557. PubMed ID: 29242186
[TBL] [Abstract][Full Text] [Related]
45. Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease.
Rip J; de Bruijn MJW; Appelman MK; Pal Singh S; Hendriks RW; Corneth OBJ
Front Immunol; 2019; 10():95. PubMed ID: 30761150
[TBL] [Abstract][Full Text] [Related]
46. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis.
Renand A; Cervera-Marzal I; Gil L; Dong C; Garcia A; Kervagoret E; Aublé H; Habes S; Chevalier C; Vavasseur F; Clémenceau B; Cardon A; Judor JP; Mosnier JF; Tanné F; Laplaud DA; Brouard S; Gournay J; Milpied P; Conchon S
J Hepatol; 2020 Dec; 73(6):1379-1390. PubMed ID: 32649971
[TBL] [Abstract][Full Text] [Related]
47. Rheumatoid factor-producing CD21low anergic clonal B-cells in essential mixed cryoglobulinaemia: a model for autoantigen-driven pathogenesis of infectious and non-infectious cryoglobulinaemias.
Del Padre M; Minafò YA; Marrapodi R; Radicchio G; Granata M; Camponeschi A; Fiorilli M; Quartuccio L; De Vita S; Casato M; Colantuono S; Visentini M
Clin Exp Rheumatol; 2020; 38 Suppl 124(2):139-147. PubMed ID: 31969220
[TBL] [Abstract][Full Text] [Related]
48. A flow cytometry-based strategy to identify and express IgM from VH1-69+ clonal peripheral B cells.
Charles ED; Orloff MI; Dustin LB
J Immunol Methods; 2011 Jan; 363(2):210-20. PubMed ID: 20875420
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus (HCV) infection of peripheral blood mononuclear cells in patients with type II cryoglobulinemia.
Jabłońska J; Ząbek J; Pawełczyk A; Kubisa N; Fic M; Laskus T; Radkowski M
Hum Immunol; 2013 Dec; 74(12):1559-62. PubMed ID: 23993984
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia.
Perotti M; Ghidoli N; Altara R; Diotti RA; Clementi N; De Marco D; Sassi M; Clementi M; Burioni R; Mancini N
Autoimmun Rev; 2008 Jun; 7(6):468-72. PubMed ID: 18558364
[TBL] [Abstract][Full Text] [Related]
51. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
He B; Qiao X; Cerutti A
J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
[TBL] [Abstract][Full Text] [Related]
52. TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.
Simchoni N; Cunningham-Rundles C
J Immunol; 2015 Apr; 194(7):3035-44. PubMed ID: 25740945
[TBL] [Abstract][Full Text] [Related]
53. Anti-C1q in chronic hepatitis C virus genotype IV infection: association with autoimmune rheumatologic manifestations.
Fadda SH; Bassyouni IH; Hamdy A; Foad NA; Wali IE
Immunol Invest; 2015; 44(1):45-55. PubMed ID: 25028787
[TBL] [Abstract][Full Text] [Related]
54. Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies.
Atta AM; Oliveira IS; Sousa GM; Paraná R; Atta ML
Microb Pathog; 2010 Feb; 48(2):53-6. PubMed ID: 20005287
[TBL] [Abstract][Full Text] [Related]
55. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
[TBL] [Abstract][Full Text] [Related]
56. Hepatitis C virus-associated B-cell proliferation--the role of serum B lymphocyte stimulator (BLyS/BAFF).
Sène D; Limal N; Ghillani-Dalbin P; Saadoun D; Piette JC; Cacoub P
Rheumatology (Oxford); 2007 Jan; 46(1):65-9. PubMed ID: 16782735
[TBL] [Abstract][Full Text] [Related]
57. Clonal CD27+ CD19+ B cell expansion through inhibition of FC gammaIIR in HCV(+) cryoglobulinemic patients.
De Re V; Pavan A; Sansonno S; Sansonno D; Racanelli V
Ann N Y Acad Sci; 2009 Sep; 1173():326-33. PubMed ID: 19758169
[TBL] [Abstract][Full Text] [Related]
58. Characterization of antibodies directed against the immunoglobulin light kappa chain variable chain region (VK) of hepatitis C virus-related type-II mixed cryoglobulinemia and B-cell proliferations.
de Re V; Simula MP; Pavan A; Garziera M; Marin D; Dolcetti R; de Vita S; Sansonno D; Geremia S; Toffoli G
Ann N Y Acad Sci; 2009 Sep; 1173():152-60. PubMed ID: 19758144
[TBL] [Abstract][Full Text] [Related]
59. B-cells and mixed cryoglobulinemia.
Ferri C; Antonelli A; Mascia MT; Sebastiani M; Fallahi P; Ferrari D; Giunti M; Pileri SA; Zignego AL
Autoimmun Rev; 2007 Dec; 7(2):114-20. PubMed ID: 18035320
[TBL] [Abstract][Full Text] [Related]
60. Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions.
Valentini G; Mantelli A; Persico M; Tuccillo C; Del Vecchio Blanco G; Morisco F; Improta RD; Migliaresi S; Gualdieri L; Caporaso N
Clin Exp Rheumatol; 1999; 17(1):75-9. PubMed ID: 10084036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
